Press Releases for the Psychedelics Industry | Page 10 of 37

Psychedelics News

Press Releases

28 Apr 2021

Awakn Life Sciences Initiates New Chemical Entity Development Program With Evotec As Research Partner And Addiction Expert, Prof. David Nutt, As Program Lead

Defining clear development pathway for next generation of psychedelic medicines to treat addiction Awakn announces today the initiation of a new chemical entity (NCE) development program to strengthen Awakn’s pipeline...

By Microdose

Press Releases

28 Apr 2021

Lobe Sciences Enters into LOI with Core One Labs to Form a Joint Venture for the Clinical Development of Biosynthetic Psilocybin

Vancouver, British Columbia–(Newsfile Corp....

By Microdose

Press Releases

28 Apr 2021

Mindset Pharma Engages KCSA Strategic Communications to Provide Investor Relations Services

Toronto, Ontario–(Newsfile Corp....

By Microdose

Press Releases

27 Apr 2021

Lobe Sciences Enters into Joint Venture with Virtual Psychedelics Incorporated to Develop Multi-Sensory Pods for Clinical Psychedelic Use

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

26 Apr 2021

Mindset Pharma Invited to Present at H.C. Wainwright “Psychedelics in Psychiatry and Beyond” Virtual Conference

Toronto, Ontario–(Newsfile Corp....

By Microdose

Press Releases

26 Apr 2021

Numinus Announces Phase 1 Clinical Trial of Natural Psilocybin Mushroom Extraction Prepared at Company Lab

Clinical trial will evaluate safety and psychoactive properties of natural Psilocybin product extracted and formulated at 7,000-square-foot laboratory in British Columbia, Canada VANCOUVER, BC, April 26, 2021 /CNW/ - Numinus...

By Microdose

Press Releases

22 Apr 2021

NeonMind Announces New Specialty Clinics Division to Deliver Innovative Mental Health Services, Appoints New VP, Corporate Development

Vancouver, British Columbia–(Newsfile Corp....

By Microdose

Press Releases

20 Apr 2021

Lobe Sciences Appoints Benjamin Kelmendi, MD from Yale University to Scientific Advisory Board

By Microdose

Press Releases

20 Apr 2021

Tryp Therapeutics Reports on Key Milestones for 2021

San Diego, California–(Newsfile Corp....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result